Outcomes and Trends of Anal Squamous Cell Carcinoma in Queensland: A 26‐Year Review
4 affiliations
- 1Department of Colorectal Surgery Princess Alexandra Hospital Brisbane Queensland Australia
- 2Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne Victoria Australia
- 3Department of Cancer Surgery Peter MacCallum Cancer Centre Melbourne Victoria Australia
- 4Department of Surgery University of Queensland Brisbane Queensland Australia
Abstract
Background: Anal cancer is rare, with anal squamous cell carcinoma (ASCC) being the most common histological type. ASCC incidence has rapidly increased in western populations over recent decades; however, outcomes for patients in Queensland, Australia, have not been previously described. The aim of this study was to report on local ASCC incidence and survival over time and identify predictive factors for survival.
Methods: A prospectively maintained database was searched to identify anal cancer cases in Queensland between January 1991 and December 2016. Kaplan–Meier analysis was used to calculate overall survival (OS) of all anal cancer patients. Further analysis was performed for ASCC patients specifically relating to age (< 60 years old, > 60 years old), era of diagnosis (1991–2010, 2011–2016), geographical remoteness (urban and remote) and whether they required salvage surgery.
Results: A total of 1106 patients were included. Eighty two percent (899 patients) were diagnosed with ASCC. ASCC incidence increased by 54.4% over the study period. Five‐year OS of ASCC, adenocarcinoma and melanoma was 67%, 46.6% and 25.5%, respectively. Five‐year OS of ASCC patients who underwent salvage surgery was 56%. Though age significantly predicted survival (p < 0.001), era of diagnosis and geographical remoteness were not significant prognostic factors (p = 0.11 and p = 0.8).
Conclusion: This study is the first state‐wide assessment of ASCC outcomes in Queensland across 26 years. A rapidly increasing incidence and mortality rate was observed. Though younger ASCC patients have better outcomes, there is no survival disadvantage to geographic remoteness. Survival outcomes have not changed significantly throughout the study period.
Related
- Survival Outcomes of Post‐Induction Treatment Strategies in Patients With Partial Response Hypopharyngeal Squamous Cell Carcinoma: A Propensity Score‐Weighted Analysis
- Synchronous laryngeal squamous cell carcinoma and papillary urothelial carcinoma of the bladder: a case report and literature review
- Prognostic value of the Hippo signaling pathway in oral squamous cell carcinoma: a systematic review and meta-analysis
- Squamous cell carcinoma in situ and syringocystadenocarcinoma papilliferum overlap in an Asian patient: A case report and review of the literature
- Integration of Immune checkpoint inhibitors within the definitive radiotherapy-based treatment continuum for locally advanced mucosal head and neck squamous cell carcinoma: a scoping review protocol
BibTeX
@article{liesegang2026outcomes,
title = {{Outcomes and Trends of Anal Squamous Cell Carcinoma in Queensland: A 26‐Year Review}},
author = {Amanda G. Liesegang and Joseph C. Kong and Nicholas Lutton and Glen R. Guerra},
journal = {Anz Journal of Surgery},
year = {2026},
month = sep,
doi = {10.1111/ans.70930},
url = {https://doi.org/10.1111/ans.70930},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Outcomes and Trends of Anal Squamous Cell Carcinoma in Queensland: A 26‐Year Review
AU - Amanda G. Liesegang
AU - Joseph C. Kong
AU - Nicholas Lutton
AU - Glen R. Guerra
PY - 2026
DA - 2026/09/10
JO - Anz Journal of Surgery
DO - 10.1111/ans.70930
UR - https://doi.org/10.1111/ans.70930
AB - Background: Anal cancer is rare, with anal squamous cell carcinoma (ASCC) being the most common histological type. ASCC incidence has rapidly increased in western populations over recent decades; however, outcomes for patients in Queensland, Australia, have not been previously described. The aim of this study was to report on local ASCC incidence and survival over time and identify predictive factors for survival. Methods: A prospectively maintained database was searched to identify anal cancer cases in Queensland between January 1991 and December 2016. Kaplan–Meier analysis was used to calculate overall survival (OS) of all anal cancer patients. Further analysis was performed for ASCC patients specifically relating to age (< 60 years old, > 60 years old), era of diagnosis (1991–2010, 2011–2016), geographical remoteness (urban and remote) and whether they required salvage surgery. Results: A total of 1106 patients were included. Eighty two percent (899 patients) were diagnosed with ASCC. ASCC incidence increased by 54.4% over the study period. Five‐year OS of ASCC, adenocarcinoma and melanoma was 67%, 46.6% and 25.5%, respectively. Five‐year OS of ASCC patients who underwent salvage surgery was 56%. Though age significantly predicted survival (p < 0.001), era of diagnosis and geographical remoteness were not significant prognostic factors (p = 0.11 and p = 0.8). Conclusion: This study is the first state‐wide assessment of ASCC outcomes in Queensland across 26 years. A rapidly increasing incidence and mortality rate was observed. Though younger ASCC patients have better outcomes, there is no survival disadvantage to geographic remoteness. Survival outcomes have not changed significantly throughout the study period.
SN - 1445-1433
SN - 1445-2197
ER -